title: Response to "Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?".
authors.affiliation: Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
authors.forename: Agnès
authors.initials: A
authors.lastname: Poirier
authors.affiliation: Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
authors.forename: Mohammed
authors.initials: M
authors.lastname: Ullah
authors.affiliation: Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
authors.forename: Christoph
authors.initials: C
authors.lastname: Funk
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000037:antagonists & inhibitors*; D000818:Animals; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D004364:Pharmaceutical Preparations / Q000378:metabolism*
chemical_list: D018528:ATP-Binding Cassette Transporters; D009363:Neoplasm Proteins; D004364:Pharmaceutical Preparations